# BridgeBio Oncology Therapeutics, Inc.: Form 8-K, filed Aug 4, 2025

- Company: [BridgeBio Oncology Therapeutics, Inc.](/companies/bbot.md) (CIK 1869105)
- Form: 8-K
- Filed: 2025-08-04
- Accepted by EDGAR: Aug 4, 2025, 16:45 ET
- Period: 2025-08-04
- Accession: 0001213900-25-071392
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1869105/000121390025071392/ea0251413-8k425_helix2.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1869105/000121390025071392/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1869105/000121390025071392/ea0251413-8k425_helix2.htm

Filed Aug 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-071392. Last ingested by Listed: Nov 5, 2026, 16:25 ET. No prices; not investment advice.